Table 1.
Demographical and clinical data.
| Parameter | Group 1 Survivors (n = 198) |
Group 2 Deceased (n = 26) |
p-Value |
|---|---|---|---|
| Gender M/F | 174 (88%)/25 (12%) | 24 (92%)/2 (8%) | p = 0.5483 |
| Age | 65 +/− 9 | 67 +/− 9 | p = 0.2869 |
| Concomitant diseases: | |||
| 1. arterial hypertension | 166 (84%) | 21 (81%) | p = 0.6973 |
| 2. DM | 78 (39%) | 9 (65%) | p = 0.0116 |
| 3. Stroke | 5 (3%) | 8 (31%) | p < 0.0001 |
| 4. Hypercholesterolemia | 134 (68%) | 18 (70%) | p = 0.8368 |
| 5. PAD | 29 (15%) | 11 (42%) | p = 0.0008 |
| Surgical indication: | p = 0.5650 | ||
| 1. LM disease | 102 (52%) | 12 (46%) | p = 0.5629 |
| 2. 3 vessels disease | 88 (44%) | 13 (50%) | p = 1.0000 |
| 3. 2 vessels disease | 8 (4%) | 1 (4%) | |
| Echocardiographic results | |||
| 1. LV diameter (mm) | 47 +/− 6 | 48 +/− 6 | p = 0.4257 |
| 2. LVEF (%) | 54 +/− 8 | 50 +/− 7 | p = 0.0159 |
| Surgery: | |||
| 1. overall time (min) | 141 +/− 42 | 139 +/− 39 | p = 0.8182 |
| 2. Mean anastomosis | 2.3 +/− 0.7 | 2.3 +/− 0.7 | p = 1.0000 |
| Hospitalization time (days) | 8.8 +/− 3 | 13 +/− 10 | p = 0.0433 |
| (excluding in hospital mortality) | (10 +/− 4) |
Abbreviations: COPD—chronic obstructive pulmonary disease, DM—diabetes mellitus, LV—left ventricle, LVEF—left ventricle ejection fraction, PAD—peripheral artery disease.